Excel Industries Limited
EXCELINDUS · NSE · Basic Materials
With a 20% margin of safety, our buy-below price is ₹1,234.9.
Piotroski F-score 3/9 — quality of earnings & balance sheet.
Investability checklist
- ✕ROE above 15%4.6%
- ✓Low debt (D/E < 0.5)0.00x
- ✕Positive free cash flow
- ✓Revenue growth > 10%14%
- ✕Earnings growing-1%
- ✕Net margin ≥ 10%6.9%
- ✓Current ratio > 1.52.49
- ✓Below our fair value
- ✓Margin of safety ≥ 20%
- ✕Above 200-day average
- ✕Above 50-day average
- –Positive 1-year return
- ✕Altman Z in safe zoneZ 2.55
- ✕Piotroski ≥ 73/9
1-year price
EOD · 2026-06-16Our scores
Durability rewards strong, low-debt, profitable businesses; Valuation rewards stocks cheap vs their sector; Momentum rewards strong price trends.
Quarterly results
Annual financials
Shareholding
Promoter holding via insider stake; institutional via reported holdings.
Key fundamentals
SWOT snapshot
Strengths
- •Lightly leveraged balance sheet.
Weaknesses
- •Low return on equity (4.6%).
- •Price below its 200-day moving average (downtrend).
- •Weak Piotroski score (3/9).
Opportunities
- •Revenue growing (14% YoY).
- •Trading in our value buy zone versus sector peers.
- •Trades ~67% below our estimated fair value.
Threats
- •Earnings contracting year on year.
About Excel Industries Limited
Excel Industries Limited engages in manufactures and sells chemicals, and environmental and biotech products and services in India and internationally. The company offers specialty chemicals, intermediates and actives catering to various end users like agrochemicals, water treatment, soaps and detergents, lube oil additives, mining chemicals, polymer additives and pharmaceuticals; and active pharmaceutical ingredients (APIs), as well as agrochemical inputs, biocides, soil and
More in Basic Materials
Our verdict, fair value, financial-health and checklist are StocksWizard's own estimates, computed from public end-of-day data using standard models (DCF, relative valuation, Altman Z, Piotroski). For information only — not investment advice or a recommendation. Verify independently before investing.